Pharmafile - Research and Development News
The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the non-profit Health Care Cost Institute (...
British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion).
Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first...
The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, approving...
Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control drug prices, according...
Eli Lilly's Lartruvo failed to present clinical benefit in the treatment of advanced or metastatic soft tissue sarcoma (STS) when used in...
Top ten stories on Pharmafile.com this week!
Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) destroy...
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between 2001 and 2015.
FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that oversees the clinical...
